A detailed history of Coppell Advisory Solutions Corp. transactions in Novo Nordisk A S stock. As of the latest transaction made, Coppell Advisory Solutions Corp. holds 19,841 shares of NVO stock, worth $2.12 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
19,841
Previous 9,361 111.95%
Holding current value
$2.12 Million
Previous $1.48 Billion 72.44%
% of portfolio
0.48%
Previous 0.48%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $1.07 Million - $1.42 Million
10,480 Added 111.95%
19,841 $2.55 Billion
Q1 2023

May 10, 2023

SELL
$132.34 - $159.14 $324,365 - $390,052
-2,451 Reduced 20.75%
9,361 $1.48 Billion
Q4 2022

Feb 17, 2023

BUY
$102.55 - $135.33 $1.21 Million - $1.6 Million
11,812 New
11,812 $1.6 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $242B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Coppell Advisory Solutions Corp. Portfolio

Follow Coppell Advisory Solutions Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions Corp., based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions Corp. with notifications on news.